Product Product catalog catalog insulation adhesives duct sealers duct sealers silicones sPray Produ sPray Products
![Dyne Therapeutics Presents Preclinical Data from its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 at World Muscle Society 2022 Congress - CureDuchenne Dyne Therapeutics Presents Preclinical Data from its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 at World Muscle Society 2022 Congress - CureDuchenne](https://cureduchenne.org/wp-content/uploads/2023/02/hC-Bioscience1.png)
Dyne Therapeutics Presents Preclinical Data from its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 at World Muscle Society 2022 Congress - CureDuchenne
Product Product catalog catalog insulation adhesives duct sealers duct sealers silicones sPray Produ sPray Products
![Dyne Therapeutics Presents Preclinical Data from its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 at World Muscle Society 2022 Congress - CureDuchenne Dyne Therapeutics Presents Preclinical Data from its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 at World Muscle Society 2022 Congress - CureDuchenne](https://cureduchenne.org/wp-content/uploads/2023/02/LYNX-TRIAL2.png)
Dyne Therapeutics Presents Preclinical Data from its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 at World Muscle Society 2022 Congress - CureDuchenne
![Dyne Therapeutics Demonstrates FORCE<sup>TM</sup> Platform's Potential to Deliver Potent Exon-Skipping Molecules Directly to Muscle to Treat Duchenne Muscular Dystrophy Dyne Therapeutics Demonstrates FORCE<sup>TM</sup> Platform's Potential to Deliver Potent Exon-Skipping Molecules Directly to Muscle to Treat Duchenne Muscular Dystrophy](https://www.dyne-tx.com/wp-content/themes/dynetxdev2020/images/rdd-2.png)
Dyne Therapeutics Demonstrates FORCE<sup>TM</sup> Platform's Potential to Deliver Potent Exon-Skipping Molecules Directly to Muscle to Treat Duchenne Muscular Dystrophy
![Dyne Therapeutics Demonstrates FORCE<sup>TM</sup> Platform's Potential to Deliver Potent Exon-Skipping Molecules Directly to Muscle to Treat Duchenne Muscular Dystrophy Dyne Therapeutics Demonstrates FORCE<sup>TM</sup> Platform's Potential to Deliver Potent Exon-Skipping Molecules Directly to Muscle to Treat Duchenne Muscular Dystrophy](https://www.dyne-tx.com/wp-content/themes/dynetxdev2020/images/rdd-1.png)